Canaccord Genuity Initiates Coverage of Alterity Therapeutics with Speculative Buy Recommendation

jueves, 18 de diciembre de 2025, 2:53 am ET1 min de lectura
ATHE--

Canaccord Genuity initiates coverage of Alterity Therapeutics Limited with a Speculative Buy recommendation. There are 17 funds reporting positions in Alterity Therapeutics Limited, with an average portfolio weight of 0.01%. Twin Lakes Capital Management holds 139K shares, while HB Wealth Management holds 58K shares. Citadel Advisors and Bnp Paribas Arbitrage also hold shares in the company.

Canaccord Genuity Initiates Coverage of Alterity Therapeutics with Speculative Buy Recommendation

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios